Nimodipine and TMB-8 potentiate the AMPA-induced lesion in the basal ganglia

Neurochemistry International

Volumn 44, Issue 4, 2004, Pages 287-291

  Petegnief, Valérie ^a,b   Ursu, Gloria ^a   Bernal, Fabian ^a   Mahy, Nicole ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Nimodipine; TMB 8

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM; CALCIUM CHANNEL L TYPE; NIMODIPINE;

ANIMAL MODEL; ARTICLE; BASAL GANGLION; CALCIFICATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; ENDOPLASMIC RETICULUM; GLIOSIS; GLOBUS PALLIDUS; MACROGLIA; MALE; NERVE CELL NECROSIS; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RAT;

EID: 0242268072     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00136-0     Document Type: Article

References (36)

1. Bencherif, M.C.M., Eisenhour, R.J., Prince, P.M., Lippiello, P.M., Lukas, R.J., 1995. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J. Pharmacol. Exp. Ther. 275, 1418-1426.
2. Bernal F., Andrés N., Samuel D., Kerkerian-LeGoff L., Mahy N. Age-related resistance to α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-induced hippocampal lesion. Hippocampus. 10:2000;296-304.
3. Bielenberg G.W., Burniol M., Rösen R., Klaus W. Effects of nimodipine on infarct size and cerebral acidosis after middle cerebral artery occlusion in the rat. Stroke. 21:1990;IV-90-IV-92.
4. Chiou G.C.Y., Hong S.J. Prevention and reduction of neuronal damage in ischaemic strokes by w-(N,N′-diethylamino)-n-alkyl-3,4,5- trimethoxybenzoate compounds. J. Pharmacol. Exp. Ther. 275:1995;474-478.
5. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
6. Corso T.D., Mostafa H.M., Collins M.A., Neafsey E.J. Brain neuronal degeneration caused by episodic alcohol intoxication in rats: effects of nimodipine. Alcohol. Clin. Exp. Res. 22:1998;217-224.
7. Doutheil J., Paschen W. Effects of 3,4,5-trimethoxybenzoic acid 8-diethylamino-octyl ester (TMB-8) on neuronal calcium homeostasis, protein synthesis, and energy metabolism. Pharmacol. Toxicol. 85:1999;85-91.
8. Drian M.J., Bardoul M., Konig N. Blockade of AMPA/kainate receptors can either decrease or increase the survival of cultured neocortical cells depending on the stage of maturation. Neurochem. Int. 38:2001;509-517.
9. Frandsen A., Schousboe A. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5- methylisoxazol-4-yl) propionate and kainate in cultured cerebral cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2590-2594.
10. GepdIremen A., DuzenlI S., Hacimuftuoglu A., Suleyman H., Oztag S. The effects of dantrolene alone or in combination with nimodipine in glutamate-induced neurotoxicity in cerebellar granular cell cultures of rat pups. Pharmacol. Res. 43:2001;241-244.
11. Ghersi C., Bonfanti A., Manzari B., Feligioni M., Raiteri M., Pittaluga A. Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists. Neurochem. Int. 42:2003;283-292.
12. Gordon R.K., Chiang P.K. Differential allosteric effects of (8-N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate-HCl (TMB-8) on muscarinic receptor subtypes. FEBS Lett. 2557:1989;383-387.
13. 2+ antagonist in cultured mouse cortical neurones. Neuroreport. 5:1994;605-608.
14. Hack N., Balázs R. Selective stimulation of excitatory amino acid receptor subtypes and the survival of granule cells in culture: effect of quisqualate and AMPA. Neurochem. Int. 25:1994;235-241.
15. Hata R., Maeda K., Hermann D., Mies G., Hossmann K.A. Evolution of brain infarction after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 20:2000;937-946.
16. Hertz L., Bender A.S., Woodbury D.M., White H.S. Potassium-stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine. J. Neurosci. Res. 22:1989;209-215.
17. Koh J.Y., Goldberg M.P., Hartley D.M., Choi D.W. Non-NMDA receptor-mediated neurotoxicity in cortical culture. J. Neurosci. 10:1990;693-705.
18. Mahy N., Prats A., Riveros A., Andrés N., Bernal F. Basal ganglia calcification induced by excitotoxicity: an experimental model characterised by electron microscopy and X-ray microanalysis. Acta Neuropathol. 98:1999;217-225.
19. 2+ antagonist (8-N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in smooth muscle. Eur. J. Pharmacol. 27:1974;25-33.
20. Malcolm C.S., Ritchie L., Grieve A., Griffiths R. A prototypic intracellular calcium antagonist, TMB-8, protects cultured cerebellar granule cells against the delayed, calcium-dependent component of glutamate neurotoxicity. J. Neurochem. 66:1996;2350-2360.
21. Marihno M.M.F., de Bruin V.M.S., de Sousa F.C.F., Aguiar L.M.V., de Pinho R.S.N., Viana G.S.B. Inhibitory action of a calcium channel blocker (nimodipine) on seizures and brain damage induced by pilocarpine and lithium-pilocarpine in rats. Neurosci. Lett. 235:1997;13-16.
22. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23:2000;222-229.
23. Mattsson P., Aldskogius H., Svensson M. Nimodipine-induced improved survival rate of facial motor neurons following intracranial transection of the facial nerve in the adult rat. J. Neurosurg. 90:1999;760-765.
24. Palmer F.B., Byers D.M., Spence M.W., Cook H.W. Calcium-independent effects of TMB-8. Modification of phospholipid metabolism in neuroblastoma cells by inhibition of choline uptake. Biochem. J. 286:1992;505-512.
25. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, second ed. Academic Press, Sydney.
26. Petegnief V., Saura J., Dewar D., Cummins D.J., Dragunow M., Mahy N. Long-term effects of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Neuroscience. 94:1999;105-115.
27. Prehn J.H., Lippert K., Krieglstein J. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur. J. Pharmacol. 292:1995;179-189.
28. Puro D.G., Mano T. Modulation of calcium channels in human retinal glial cells by basic fibroblast growth factor: a possible role in retinal pathology. J. Neurosci. 11:1991;1873-1880.
29. Rothman S.M. The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 5:1985;1483-1489.
30. Saura J., Boatell M.L., Bendahan G., Mahy N. Calcium deposits formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesions. Eur. J. Neurosci. 7:1995;1569-1578.
31. 2+-ATPase. Biochim. Biophys. Acta. 772:1984;29-36.
32. Simpson A.W., Hallam T.J., Rink T.J. TMB-8 inhibits secretion evoked by phorbol ester at basal cytoplasmic free calcium in quin2-loaded platelets much more effectively than it inhibits thrombin-induced calcium mobilisation. FEBS Lett. 176:1984;139-143.
33. + channel. Eur. J. Pharmacol. 226:1992;175-177.
34. Vaca K., Wendt E. Divergent effects of astroglial and microglial secretions on neuron growth and survival. Exp. Neurol. 118:1992;62-72.
35. Vizi E.S., Mike A., Tarnawa I. 2,3-Benzodiazepines (GYKI 52466 and analogs): negative allosteric modulators of AMPA receptors. CNS Drug Rev. 2:1996;91-126.
36. Zhu D., Liu G., Hua W. Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells. Life Sci. 65:1999;PL 221-PL 231.